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ABSTRACT 
 
     The articular cartilage present in joints is permanently subjected to physical stress, 
thus producing injuries and consequently pain. Chondrocytes are responsible for 
repairing this damage, but often the reparation tissue is inadequate. The application of 
melatonin to human articular chondrocytes may be a better solution, by generating a 
good extracellular matrix. Human chondrocytes were assayed in the presence of 
melatonin, demonstrating that these cells generate more extracellular matrix indicated 
by the increased Alcian blue staining. This effect of melatonin was concentration- 
dependent and presented a pD2 value of 6.8  0.1 (n=5). Melatonin also significantly 
promotes the production of collagen II quantified by western-blot analysis. The effect of 
melatonin on the collagen II production is also concentration-dependence, with a pD2 
value of 6.9  0.2 (n=5). In contrast, melatonin had little effect on the collagen X. The 
antagonistic study by its non-selective membrane receptor blocker luzindole or its MT2 
specific blocker DH-97 identified that these actions of melatonin are mediated by 
melatonin membrane receptors, mainly by MT2. In summary, melatonin stimulates the 
production of extracellular matrix and collagen II in chondrocytes and these actions 
may have significantly clinical implications since it may benefit the autologous 
chondrocyte transplantations, the only way to maintain and repair the damaged 
cartilage.  
 
Keywords: melatonin, cartilage, chondrocytes, extracellular matrix, melatonin 
membrane receptor.  
 
 
1. INTRODUCTION 
 
     The articular cartilage, which is located in the synovial joints of relevant bones, such 
as knees or ankles, is the most common type of cartilage, characterized by being rich in 
proteoglycans as well as collagen II. The cartilage is continuously subjected to great 
stress, and, thus it demands the substantial replacement with the extracellular matrix 
which is produced by the chondrocytes (1). An excess of cartilage extracellular matrix 
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loss will produce pathologies that can incapacitate the individual from living a normal 
life (2). The only way to restore the damaged cartilage is by surgery, which is often 
combined with autologous chondrocyte transplantation. Basically, a sample of healthy 
cartilage is taken and cells are multiplied, these cells are then implanted in the damaged 
cartilage after removing the injured area (3). 
     Several strategies have been carried out to perform chondrocyte implantation, 
nonetheless, no studies have been tried to stimulate these cells to produce more 
extracellular matrix. Physiologically, if more extracellular matrix was generated, after 
the chondrocyte implantation, the healing and repair processes of the cartilage would be 
accelerated. 
     An interesting molecule with a variety of physiological actions is melatonin. 
Melatonin, either acting by itself, or by stimulating melatonin membrane receptors, 
mediates many relevant activities such as the control of free radicals (4, 5). It can 
stimulate lymphocyte maturation (6) or regulates some physiological processes among 
many other actions (7, 8).  
     In the cartilage, the activities of melatonin have been observed in normal and 
pathological processes such as osteoarthritis (9) or intervertebral disc degeneration, 
where melatonin acts via Sirt1 expression (10). Moreover, melatonin can ameliorate 
rheumatoid arthritis reducing inflammation, limiting cartilage degradation and bone 
erosion (11).  
     The articular cartilage is lack of vascularization, thus this feature limits the 
circulatory melatonin reaching the area and therefore this may contribute to chondrocyte 
malfunction. Nonetheless, melatonin has been described in the human synovial fluid 
(12) and as such it may plays a critical role in the physiology of chondrocytes. Till now, 
the exact function(s) of the synovial melatonin is not clear. We speculate that melatonin 
may stimulate the production of extracellular matrix in the human cartilage. This 
possibility has never been fully investigated yet. To test this hypothesis, in the present 
study, the potentially stimulatory effects of melatonin on the production of extracellular 
matrix is explored. In addition, collagen II, one of the most relevant proteins presented 
in extracellular medium, is also measured when human chondrocytes are treated with 
melatonin. 
 
2. MATERIALS AND METHODS 
 
2.1 Human articular chondrocytes 
 
     Human chondrocytes, used throughout the study, were obtained from the articular 
cartilage (knees) of healthy individuals (n=5). These cells were kindly provided by Dr. 
Pedro Guillén (Clinica CEMTRO, Madrid, Spain), and followed the Ethical Committee 
Standards of Clinica CEMTRO.  
     Each piece of healthy cartilage was placed in a petri dish and cut into small portions 
using a sterile razor blade. The fragments were carefully placed in a sterile 50 mL tube 
and isolation of cells was performed by enzymatic treatment with 1 mg/mL collagenase 
A (Roche Diagnostics GmbH, Mannheim, Germany) at 37°C overnight. The processed 
samples were filtered through a 70 µm gauge nylon cell strainer (BD Falcon, Franklin 
Lakes, NJ) connected to a clean 50 mL tube. To recover the maximum number of cells, 
the cell strainer was washed with 10 mL of DMEM. The sample was centrifuged for 5 
minutes at 1,800 rpm at room temperature discarding the supernatant. After adding 
other 20 ml of DMEM at room temperature, the supernatant was discarded, and 
additional 20 mL of DMEM was added to the tube to be further centrifuged under the 
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same conditions. The pellet was re-suspended and cultured in high glucose Dulbecco's 
modified Eagle's medium (Gibco/Invitrogen, Carlsbad, CA) containing 10% foetal 
bovine serum (Sigma-Aldrich, St. Louis, MO) and 0.05 penicillin/ streptomycin 
(Gibco/Invitrogen) at 37ºC in humidified atmosphere with 5% CO2 and 95% air. 
 
2.2 Extracellular matrix analysis 
 
     Cartilage matrix deposition in human articular chondrocytes was measured using 
Alcian blue staining. Cells were seeded at a density of 2×104  cells/well in six-multiwell 
dishes. When cells reached the confluence, on the 3rd day, cells were treated  with 
melatonin at the given concentration. The cells were cultured with fresh medium 
containing melatonin (or/and any other given compound) every 3 days. Cultures were 
monitored over a total period of 15 days. At different time points, 3, 7, 10 and 15 days, 
extracellular matrix was analysed using Alcian Blue staining as previously described 
(13). 
 
2.3 Cell viability 
 
     Cell viability throughout the whole experimental period (15 days) was performed by 
using trypan blue staining. Viable (unstained) cells were counted using a 
hemocytometer under the light microscope. Experiments were performed in triplicate. 
 
2.4 Melatonin concentration-response studies 
 
     The concentration-response curves, either measuring extracellular matrix deposition 
or protein quantification by western-blot, were performed by treating the cells with 
different concentrations of melatonin ranging from 10-9 to 10-4 M, and the extracellular 
matrix or protein levels were measured at the 15th day of the culture. The medium 
containing the given concentration of melatonin was changed every three days. 
 
2.5 Western-blot analysis 
 
     To analyze and quantify both, collagen II and collagen X, lysates from each well (45 
μg of protein) were subjected to 10% SDS-polyacrilamide gel electrophoresis to be 
further transferred to nitrocellulose membranes. Afterwards, the membranes were 
blocked and incubated overnight with collagen II and collagen X antibodies (ab188570 
and ab58632, respectively, abcam, Cambridge, USA) at a dilution of (1:1,000). After 
washing, blots were incubated with peroxidase-conjugated secondary antibody. 
Development was performed using ECL system (Amersham, Buckinghamshire, UK). 
     In order to verify the correct loading of the samples, membranes were stripped in 
62.5 mM Tris–HCl pH 6.8, 2% SDS and 100 mM 2-mercaptoethanol and re-blotted 
using ERK-2 antibody. Films were scanned and densitometric analysis was carried out 
using Kodak GL 200 Imaging system and Kodak Molecular Imaging software (Kodak, 
Rochester, NY, USA). All data shown are results representative of five independent 
experiments. 
 
2.6 Melatonin membrane receptor antagonistic studies 
 
     To demonstrate whether melatonin membrane receptors are involved in this action, 
two melatonin membrane receptor antagonists were used, that are, the non-selective 
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melatonin receptor antagonist luzindole and the MT2 selective antagonist DH-97 
(Tocris, Bristol, UK). Each antagonist alone, or both together, were pre-incubated for 30 
min at a concentration of 100 M before the melatonin (100 M) was applied. Fresh 
medium containing the given concentration of the antagonists and melatonin was 
changed every three days. 
 
2.7 Statistical analysis 
 
     All the plots and the statistical analysis were carried out with Prism Graph Pad 7 
(GraphPad Software, CA, USA). Student's t-test statistical analysis was carried out 
when necessary. The statistical significance is set up p < 0.05 and has been indicated in 
each case. 
 
3 RESULTS 
 
3.1 Effect of melatonin on extracellular matrix production in chondrocytes 
 
     Extracellular matrix production was evaluated by Alcian blue staining in human 
articular chondrocytes, treated either with vehicle or with a single dose of melatonin 
(100 M). The results showed that melatonin treatment significantly increased the 
extracellular matrix of chondrocytes at the day 15th of treatment (n=5) indicted by the 
strong Alcian blue staining. In the control group, Alcian blue staining was significantly 
weaker than that in the melatonin treated group (Fig. 1A). 
 
 
Figure 1. Effect of melatonin on extracellular matrix production in articular 
chondrocytes. 
     A: Chondrocytes were treated with a single dose of melatonin (100 M). At the 
indicated times, extracellular matrix was quantified by Alcian Blue staining of cell 
layers, following solubilisation. Dye uptake was quantified at 605 nm (*p<0.05, 
***p<0.001, vs. vehicle; n=5). B: Viable chondrocytes were determined by trypan blue 
exclusion assay. The number of viable cells in the control (without treatment) was 
normalized to 100% and was used as the reference for cells treated with melatonin. C: 
Concentration-response curve of melatonin and extracellular matrix (measuring in the 
absorbance at 605 nm) in the presence of concentrations of melatonin from 10-9 M to 
10-4 M (n=5). 
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     As to the cell viability throughout the 15 days of the study, there were no statistically 
differences to be observed between the groups (n=5) determined by trypan blue staining 
(Fig. 1B).  
     A concentration-response study showed that the effect of melatonin to stimulate the 
extracellular matrix formation of chondrocytes is dose dependent and the pD2 value 
was 6.8 ± 0.1 (EC50=0.15 µM) (n=5) (Fig. 1 C). 
 
3.2 Effect of melatonin on collagen II and collagen X production 
 
     After the observation of melatonin promoting the production of extracellular matrix 
in chondrocytes, the levels of two relevant collagens (collagen II and collagen X) both 
contributing to the extracellular matrix, were assayed at the day 15th of the study. In 
this sense, the concentration-response curves of melatonin (ranging from 10-9 to 10-4 M) 
on collagen II and collagen X were performed. The results showed that the 
concentration-dependent effects of melatonin on collagen II formation was obvious and 
the maximal effective concentration was around 10-5 M (n=5). On the contrary, 
melatonin had little effect on collagen X formation (Fig. 2).  
 
 
 
Figure 2. The concertation dependent studies of melatonin on collagen II and X 
expression. 
     A: The protein expression of collagen II was concentration dependently upregulated 
by melatonin (panel A, upper gel) while melatonin failed to upregulate the expression of 
collagen X (panel A, middle gel). B: Plot of the results obtained in panel A to obtain the 
corresponding concentration response curves for collagen II and X. Data (mean ± SD) 
(n=5 are represented in arbitrary units (a.u.) and normalized to the intensity of the 
band corresponding control (ERK2). 
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     The calculated pD2 value for collagen II is 6.9  0.2 (EC50=0.12 M) (n=5). Since 
there were no changes in collagen X levels, it was not possible to calculate a 
concentration-response curve (n=5). 
 
3.3 Effect of melatonin membrane receptor antagonists on the collagen II 
formation at the presence of melatonin. 
 
     The effect of melatonin on collagen II production was studied in the presence of the 
melatonin membrane receptor antagonists luzindole and DH-97. The non-selective 
membrane receptor antagonist luzindole, at 100 M, partially blocked melatonin (100 
M) effects on collagen II formation with a reduction of 33.3  3.6 % (n=5). When the 
selective MT2 antagonist DH-97 was used, this reduction on collagen II formation was 
increased to 73.3  2.4 % (n=5). When both antagonists were tested together the effect 
of melatonin on collagen II formation was further significantly abolished (n=5). 
 
 
Figure 3.- Effect of melatonin membrane receptor antagonists on collagen II 
formation induced by melatonin. 
     The effect of melatonin (100 M) on the expression of collagen II was partially 
antagonized by luzindole (100 M) and a stronger antagonization was observed by DH-
97 (100 M). The combination of both antagonists provided further inhibition on 
collagen II production at the present of melatonin (*p<0.05, ***p<0.001, vs. vehicle; 
n=5). 
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4. DISCUSSION 
 
     It has been observed in the current study that melatonin stimulates the physiological 
function of human articular chondrocytes to increase the production of extracellular 
matrix. Further study indicated that one of the most representative components of 
extracellular medium, collagen II, was also significantly elevated after melatonin 
treatment. The results presented here are consistent with the previous report, which also 
showed that melatonin enhanced the production of extracellular matrix in porcine 
chondrocytes (14). 
     Although the perspective of that study was to target the treatment of osteoarthritis, it 
was found that melatonin was able to induce changes in collagen II but was unable to 
modify collagen X expression. Collagen II in the extracellular matrix is the base where 
the proteoglycans, which form the cartilage extracellular milieu, carry out their turnover 
(15). This observation provides a plausible explanation as to why there is not only an 
increase in collagen II, but also a robust increase in the extracellular medium in the 
present study.  
     The lack of changes of collagen X when cells are treated with melatonin are not 
unusual since this type of collagen is more relevant in endochondral chondrocytes 
which are responsible of bone growth. In endochondral chondrocytes, collagen X is a 
marker for new bone formation and the increase in this protein indicates chondrocyte 
hypertrophy as a step prior to ossification (16). 
     Chondrocytes present in the cartilage with a correct turnover of the extracellular 
matrix are responsible for the perfect performance of joints. Excessive sports training, 
or simply aging, can lead to cartilage damage (17-19). If the chondrocytes are unable to 
renew the cartilage in an effective way, patients will suffer pain. Very often, the 
cartilage generates an abnormal extracellular matrix, termed reparation tissue, which is 
amorphous and results in pain and joint problems (20). To solve these abnormalities, 
surgery by means of autologous chondrocyte transplantation with the techniques of ICA 
or ICAM are currently available. Even though the newly generated extracellular matrix 
after autologous chondrocyte transplantation is not the same as the native tissue 
generated it is still better than that the reparation of tissue (3). 
     In the present work, it has been demonstrated that chondrocytes treated with 
melatonin improve the ability to produce more extracellular matrix. Melatonin triggers 
the formation of proteoglycans, but also contributes to the production of a relevant 
protein of collagen II. The effects of melatonin on either extracellular matrix or collagen 
II formation are concentration-dependent and its effects can be blocked by melatonin 
membrane receptor antagonists. Although the pharmacological characterization is 
preliminary, there is clear evidence that most of the effects in the present work are 
mediated by MT2. From this point of view, the use of selective agonists of the MT2 
receptors such as IIK7, may produce a more robust effect than that observed in 
melatonin. More experiments are necessary to confirm this hypothesis.  
     Collectively, melatonin, via its receptors mediated actions, can improve the 
physiological functions of articular cartilage chondrocytes to increase the extracellular 
matrix production. This aspect is very clinical relevant, since without an appropriate 
extracellular matrix production all the damage induced by the physical exercise or even 
aging, would not be properly healed in joint (21-24). Our results suggest an alternative 
that chondrocytes used for autologous transplantation can be pre-treated with melatonin 
to improve the outcome of cartilage repairing clinically.  
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